Koiji Sasaki (Koji Sasaki)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 133

Top Venues

American journal of hematology

Cancer

Leukemia

Blood cancer journal

The University of Texas MD Anderson Cancer Center

Tokyo Medical and Dental University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Texas MD Anderson Cancer Center

United States

Assistant Professor :: Department of Leukemia

Education History

Tokyo Medical and Dental University

Japan

PHD :: Department of Hematology, Graduate School of Medical Sciences

Publications

Jayastu Senapati, Koiji Sasaki, Ghayas C Issa, Jeffrey H Lipton, Jerald P Radich, Elias J Jabbour, Hagop M Kantarjian
Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood cancer journal 13 (1) (2023)
Koiji Sasaki, Fady Gh Haddad, Nicholas James Short, Nitin Jain, Ghayas Issa, Elias J Jabbour, Hagop M Kantarjian
Outcome of Philadelphia chromosome-positive chronic myeloid leukemia in the United States since the introduction of imatinib therapy-The Surveillance, Epidemiology, and End Results database, 2000-2019. Cancer (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia-Manero, Robert P Hasserjian
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia-Manero, Robert P Hasserjian
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology 98 (4) (2023)
Alexandre Bazinet, Tapan M Kadia, Nicholas James Short, Gautam Borthakur, Sa A Wang, Wei Wang, Sanam Loghavi, Jeffrey L Jorgensen, Keyur Pravinchandra Patel, Courtney D Di Nardo, Naval G Daver, Yesid Alvarado, Fadi G Haddad, Sherry R Pierce, Graciela Nogueras Gonzalez, Abhishek Maiti, Koiji Sasaki, Musa Ylimaz, Phillip A Thompson, William G Wierda, Guillermo Garcia-Manero, Michael Andreeff, Elias J Jabbour, Marina Y Konopleva, Xuelin Huang, Hagop M Kantarjian, Farhad Ravandi
Undetectable Measurable Residual Disease is Associated with Improved Outcomes in AML Irrespective of Treatment Intensity. Blood advances (2023)
Jayastu Senapati, Koiji Sasaki, Ghayas C Issa, Jeffrey H Lipton, Jerald P Radich, Elias J Jabbour, Hagop M Kantarjian
Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood cancer journal 13 (1) (2023)
Aram Bidikian, Elias J Jabbour, Ghayas C Issa, Nicholas James Short, Koiji Sasaki, Hagop M Kantarjian
Chronic Myeloid Leukemia Without Major Molecular Response After 2 Years of Treatment with Tyrosine Kinase Inhibitor. American journal of hematology (2023)
Hagop M Kantarjian, Mary Alma Welch, Koiji Sasaki
Early mortality after chemotherapy as a quality indicator-the leukemia perspective. Blood cancer journal 13 (1) (2023)
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia 37 (3) (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D Di Nardo, Keyur Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The Outcomes of Patients with Chronic Myeloid Leukemia Treated with Third-line BCR::ABL1 Tyrosine Kinase Inhibitors. American journal of hematology (2023)
Jayastu Senapati, Koiji Sasaki, Ghayas C Issa, Jeffrey H Lipton, Jerald P Radich, Elias J Jabbour, Hagop M Kantarjian
Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood cancer journal 13 (1) (2023)
Fadi G Haddad, Hagop M Kantarjian, Aram Bidikian, Elias J Jabbour, Nicholas James Short, Jing Ning, Lianchun Xiao, Naveen Pemmaraju, Courtney D Di Nardo, Tapan Mahendra Kadia, Kayleigh R Marx, Guillermo Garcia Manero, Farhad Ravandi, Koiji Sasaki, Ghayas C Issa
Association between bariatric surgery and outcomes in chronic myeloid leukemia. Cancer (2023)
Gaku Oshikawa, Koiji Sasaki
Optimizing Treatment Options for Newly Diagnosed Acute Myeloid Leukemia in Older Patients with Comorbidities. Cancers 15 (8) (2023)
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia 37 (3) (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine 29 (1) (2023)
Lucia Masarova, Prithviraj Bose, Naveen Pemmaraju, Naval G Daver, Koiji Sasaki, Helen T Chifotides, Lingsha Zhou, Hagop M Kantarjian, Zeev Estrov, Srdan Verstovsek
The role of therapy in the outcome of patients with myelofibrosis. Cancer (2023)
Aram Bidikian, Elias J Jabbour, Ghayas C Issa, Nicholas James Short, Koiji Sasaki, Hagop M Kantarjian
Chronic myeloid leukemia without major molecular response after 2 years of treatment with tyrosine kinase inhibitor. American journal of hematology 98 (4) (2023)
Alex Bataller, Fadi G Haddad, Ghayas C Issa, Koiji Sasaki, Elias Jabbour, Gautam Borthakur, Alessandra Ferrajoli, Nicholas James Short
Sudden lymphoid blast crisis after tyrosine kinase inhibitor discontinuation in chronic phase chronic myeloid leukemia: cautionary tales for appropriate molecular monitoring. Leukemia & lymphoma 64 (3) (2023)
Guillermo Montalban Bravo, Rashmi Kanagal-Shamana, Ziyi Li, Danielle Hammond, Kelly Sharon Chien, Juan Jose Rodriguez-Sevilla, Koiji Sasaki, Elias Jabbour, Courtney DiNardo, Koichi Takahashi, Nicholas James Short, Ghayas C Issa, Naveen Pemmaraju, Tapan Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Hagop Kantarjian, Guillermo Garcia Manero
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia. British journal of haematology (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine 29 (1) (2023)
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia 37 (3) (2023)
Gaku Oshikawa, Koiji Sasaki
Optimizing Treatment Options for Newly Diagnosed Acute Myeloid Leukemia in Older Patients with Comorbidities. Cancers 15 (8) (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D Di Nardo, Keyur P Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors. American journal of hematology 98 (4) (2023)
Emmanuel Almanza-Huante, Alex Bataller, Samuel Urrutia, Georgina Gener-Ricos, Robert Edward Briski, Rashmi Kanagal-Shamana, Karen H Lu, Shannon N Westin, Timothy A Yap, Koichi Takahashi, Farhad Ravandi, Yesid Alvarado, Tapan Kadia, Koiji Sasaki, Hagop M Kantarjian, Guillermo Garcia Manero
Outcomes of patients with therapy-related myeloid neoplasms after treatment with poly(ADP-ribose) polymerase proteins inhibitors for solid tumours. British journal of haematology (2023)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Sanam Loghavi, Keyur P Patel, Guillermo Montalban Bravo, Lucia Masarova, Courtney D Di Nardo, Hagop M Kantarjian
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia. Cancer 129 (7) (2023)
Kunhwa Kim, Faustine Ong, Koiji Sasaki
Current Understanding of DDX41 Mutations in Myeloid Neoplasms. Cancers 15 (2) (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D Di Nardo, Keyur P Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors. American journal of hematology 98 (4) (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine 29 (1) (2023)
Kunhwa Kim, Faustine Ong, Koiji Sasaki
Current Understanding of DDX41 Mutations in Myeloid Neoplasms. Cancers 15 (2) (2023)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Sanam Loghavi, Keyur P Patel, Guillermo Montalban Bravo, Lucia Masarova, Courtney D Di Nardo, Hagop M Kantarjian
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia. Cancer (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia-Manero, Robert P Hasserjian
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology 98 (4) (2023)
Jayastu Senapati, Koiji Sasaki, Ghayas C Issa, Jeffrey H Lipton, Jerald P Radich, Elias J Jabbour, Hagop M Kantarjian
Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood cancer journal 13 (1) (2023)
Fady Gh Haddad, Koiji Sasaki, Aram Bidikian, Ghayas C Issa, Tapan Mahendra Kadia, Nitin Jain, Yesid Alvarado, Nicholas James Short, Naveen Pemmaraju, Sanam Loghavi, Keyur P Patel, Rashmi Kanagal-Shamana, Musa Ylimaz, Lucia Masarova, Elias J Jabbour, Hagop M Kantarjian
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era. American journal of hematology (2023)
Jayastu Senapati, Koiji Sasaki, Ghayas C Issa, Jeffrey H Lipton, Jerald P Radich, Elias J Jabbour, Hagop M Kantarjian
Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood cancer journal 13 (1) (2023)
Elias J Jabbour, Fadi G Haddad, Nicholas James Short, Jayastu Senapati, Nitin Jain, Koiji Sasaki, Jeffrey L Jorgensen, Sa A Wang, Yesid Alvarado, Xuemei Wang, Courtney D Di Nardo, Lucia Masarova, Tapan M Kadia, Rebecca Garris, Farhad Ravandi, Hagop M Kantarjian
Phase II Study of Inotuzumab Ozogamicin for Measurable Residual Disease in Acute Lymphoblastic Leukemia in Remission. Blood (2023)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Sanam Loghavi, Keyur P Patel, Guillermo Montalban Bravo, Lucia Masarova, Courtney D Di Nardo, Hagop M Kantarjian
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia. Cancer 129 (7) (2023)
Samuel Urrutia, Ziyi Li, Emmanuel Almanza, Alex Bataller, Rashmi Kanagal-Shamana, Jayastu Senapati, Koiji Sasaki, Kelly Sharon Chien, Guillermo Montalban-Bravo, Courtney D Di Nardo, Gautam Borthakur, Carlos Bueso-Ramos, Sherry Pierce, Hagop M Kantarjian, Guillermo Garcia Manero
Characteristics of patients with myelodysplastic neoplasm and spliceosome mutations. Leukemia (2023)
Aram Bidikian, Elias J Jabbour, Ghayas C Issa, Nicholas James Short, Koiji Sasaki, Hagop M Kantarjian
Chronic myeloid leukemia without major molecular response after 2 years of treatment with tyrosine kinase inhibitor. American journal of hematology 98 (4) (2023)
Jayastu Senapati, Koiji Sasaki, Ghayas C Issa, Jeffrey H Lipton, Jerald P Radich, Elias J Jabbour, Hagop M Kantarjian
Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood cancer journal 13 (1) (2023)
Jayastu Senapati, Koiji Sasaki, Ghayas C Issa, Jeffrey H Lipton, Jerald P Radich, Elias J Jabbour, Hagop M Kantarjian
Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood cancer journal 13 (1) (2023)
Aram Bidikian, Elias J Jabbour, Ghayas C Issa, Nicholas James Short, Koiji Sasaki, Hagop M Kantarjian
Chronic myeloid leukemia without major molecular response after 2 years of treatment with tyrosine kinase inhibitor. American journal of hematology (2023)
Alexandre Bazinet, Hagop M Kantarjian, Naszrin Arani, Uday Popat, Alex Bataller, Koiji Sasaki, Courtney D Di Nardo, Naval G Daver, Musa Ylimaz, Hussein A Abbas, Nicholas James Short, Ghayas C Issa, Elias J Jabbour, Sherry A Pierce, Julianne Chen, Ricky Garcia, Marina Konopleva, Guillermo Garcia Manero, Amin Alousi, Elizabeth J Shpall, Richard E Champlin, Gautam Borthakur, Farhad Ravandi, Tapan Mahendra Kadia
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation. American journal of hematology (2023)
Jayastu Senapati, Warren C Fiskus, Naval G Daver, Nathaniel R Wilson, Farhad Ravandi, Guillermo Garcia Manero, Tapan Mahendra Kadia, Courtney D Di Nardo, Elias J Jabbour, Jan A Burger, Nicholas James Short, Yesid Alvarado, Nitin Jain, Lucia Masarova, Ghayas C Issa, Wei Qiao, Joseph D Khoury, Sherry Pierce, Darla Miller, Koiji Sasaki, Marina Y Konopleva, Kapil N Bhalla, Gautam Borthakur, Naveen Pemmaraju
Phase 1 Results of Bromodomain and Extraterminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Samuel Urrutia Argueta, Kelly Sharon Chien, Ziyi Li, Alex Bataller, Emmanuel Almanza, Koiji Sasaki, Guillermo Montalban Bravo, Nicholas James Short, Elias J Jabbour, Tapan Mahendra Kadia, Farhad Ravandi, Gautam Borthakur, Yesid Alvarado, Naval G Daver, Rashmi Kanagal-Shamana, Carlos Bueso-Ramos, Sherry A Pierce, Hagop M Kantarjian, Guillermo Garcia Manero
Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure. American journal of hematology (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D Di Nardo, Keyur P Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors. American journal of hematology (2023)
Wei-Ying Jen, Koiji Sasaki, Caitlin R Rausch, Courtney D Di Nardo, Tapan Mahendra Kadia, Musa Ylimaz, Gautam Borthakur, Yesid Alvarado, David McCue, Deborah Mccue, Hagop M Kantarjian, Farhad Ravandi
Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patients. Leukemia & lymphoma (2023)
Alex Bataller, Fadi G Haddad, Ghayas C Issa, Koiji Sasaki, Elias Jabbour, Gautam Borthakur, Alessandra Ferrajoli, Nicholas James Short
Sudden lymphoid blast crisis after tyrosine kinase inhibitor discontinuation in chronic phase chronic myeloid leukemia: cautionary tales for appropriate molecular monitoring. Leukemia & lymphoma (2023)
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia 37 (3) (2023)
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Timothy P Hughes, Jane F Apperley, Elza Lomaia, Sergey Voloshin, Anna G Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koiji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, J Valentín García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J Mauro
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL. Leukemia (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia-Manero, Robert P Hasserjian
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology 98 (4) (2023)
Christopher P Mill, Warren C Fiskus, Kaberi Das, John A Davis, Christine E Birdwell, Tapan Mahendra Kadia, Courtney D Di Nardo, Naval G Daver, Koichi Takahashi, Koiji Sasaki, Gerard M McGeehan, Xinjia Ruan, Xiaoping Su, Sanam Loghavi, Hagop Kantarjian, Kapil N Bhalla
Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1. Leukemia (2023)
Daniel Nguyen, Hagop M Kantarjian, Nicholas James Short, Wei Qiao, Jing Ning, Branko Cuglievan, Naval G Daver, Courtney D Di Nardo, Elias J Jabbour, Tapan Mahendra Kadia, Gautam Borthakur, Guillermo Garcia Manero, Marina Y Konopleva, Michael Andreeff, Farhad Ravandi-Kashani, Koiji Sasaki, Ghayas C Issa
Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation. Cancer (2023)
Holly A Hill, Preetesh Jain, Chi Young Ok, Koiji Sasaki, Han-Yang Chen, Michael L Wang, Ken Chen
Integrative Prognostic Machine Learning Models in Mantle Cell Lymphoma. Cancer research communications 3 (8) (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jefferey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia Manero, Robert P Hasserjian
Biologic Features and Clinical Outcomes in Newly Diagnosed Myelodysplastic Syndrome with KMT2A rearrangements. American journal of hematology (2023)
Kunhwa Kim, Faustine Ong, Koiji Sasaki
Current Understanding of DDX41 Mutations in Myeloid Neoplasms. Cancers 15 (2) (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D Di Nardo, Keyur P Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors. American journal of hematology 98 (4) (2023)
Karen A Nahmod, Koiji Sasaki, Chi Young Ok, Sanam Loghavi
Utility of p53 immunohistochemistry as a surrogate for sequencing in myeloid neoplasms: A tale of caution. American journal of hematology (2023)
Alex Bataller, Fadi G Haddad, Ghayas C Issa, Koiji Sasaki, Elias Jabbour, Gautam Borthakur, Alessandra Ferrajoli, Nicholas James Short
Sudden lymphoid blast crisis after tyrosine kinase inhibitor discontinuation in chronic phase chronic myeloid leukemia: cautionary tales for appropriate molecular monitoring. Leukemia & lymphoma 64 (3) (2023)
Aram Bidikian, Elias J Jabbour, Ghayas C Issa, Nicholas James Short, Koiji Sasaki, Hagop M Kantarjian
Chronic myeloid leukemia without major molecular response after 2 years of treatment with tyrosine kinase inhibitor. American journal of hematology 98 (4) (2023)
Jayastu Senapati, Samuel Urrutia, Sanam Loghavi, Nicholas James Short, Ghayas C Issa, Abhishek Maiti, Hussein A Abbas, Naval G Daver, Naveen Pemmaraju, Sherry A Pierce, Kelly Sharon Chien, Koiji Sasaki, Tapan M Kadia, Danielle Hammond, Gautam Borthakur, Keyur Pravinchandra Patel, Farhad Ravandi, Hagop M Kantarjian, Guillermo Garcia-Manero, Courtney D Di Nardo
Venetoclax Abrogates the Prognostic Impact of Splicing Factor Gene Mutations in Newly Diagnosed Acute Myeloid Leukemia. Blood (2023)
Michael J Mauro, Timothy P Hughes, Dong-Wook Kim, Delphine Rea, Jorge E Cortes, Andreas Hochhaus, Koiji Sasaki, Massimo Breccia, Moshe Talpaz, Oliver Ottmann, Hironobu Minami, Yeow Tee Goh, Daniel J DeAngelo, Michael C Heinrich, Valle Gómez-García de Soria, Philipp le Coutre, Francois-Xavier Mahon, Jeroen J W M Janssen, Michael Deininger, Naranie Shanmuganathan, Mark Blaine Geyer, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Matthias Hoch, Fabian Lang
Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results. Leukemia (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine (2023)
Alex Bataller, Sanam Loghavi, Yoheved Gerstein, Alexandre Bazinet, Koiji Sasaki, Kelly Sharon Chien, Danielle Hammond, Guillermo Montalban Bravo, Gautam Borthakur, Nicholas James Short, Ghayas C Issa, Tapan Mahendra Kadia, Naval G Daver, Guillin Tang, Andres Quesada, Keyur P Patel, Farhad Ravandi, Warren Fiskus, Cristopher P Mill, Hagop M Kantarjian, Kapil N Bhalla, Guillermo Garcia Manero, Betul Oran, Courtney D Di Nardo
Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants. American journal of hematology (2023)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Sanam Loghavi, Keyur P Patel, Guillermo Montalban Bravo, Lucia Masarova, Courtney D Di Nardo, Hagop M Kantarjian
Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia. Cancer 129 (7) (2023)
Jayastu Senapati, Elias J Jabbour, Marina Y Konopleva, Nicholas James Short, Guillin Tang, Naval G Daver, Partow Kebriaei, Tapan Mahendra Kadia, Naveen Pemmaraju, Koichi Takahashi, Courtney D Di Nardo, Koiji Sasaki, Gautam Borthakur, Beenu Thakral, Rashmi Kanagal-Shamana, Keyur Pravinchandra Patel, Farhad Ravandi, Kathryn G Roberts, Charles G Mullighan, Hagop M Kantarjian, Nitin Jain
Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in ABL Class Rearrangements. JCO precision oncology 7 (2023)
Hua-Jay J Cherng, Raamis Khwaja, Rashmi Kanagal-Shamana, Guillin Tang, Jan Burger, Philip Thompson, Alessandra Ferrajoli, Zeev Estrov, Koiji Sasaki, Deepa Sampath, Xuemei Wang, Hagop Kantarjian, Michael Keating, William G Wierda, Nitin Jain
TP53-altered chronic lymphocytic leukemia treated with firstline Bruton's tyrosine kinase inhibitor-based therapy: A retrospective analysis. American journal of hematology 97 (8) (2022)
Hui Yang, Guillermo Garcia Manero, Koiji Sasaki, Guillermo Montalban-Bravo, Zhenya Tang, Yue Wei, Tapan Mahendra Kadia, Kelly Sharon Chien, Diana Rush, Ha Nguyen, Awdesh Kalia, Manjunath Nimmakayalu, Carlos Bueso-Ramos, Hagop M Kantarjian, L Jeffrey Medeiros, Rajyalakshmi Luthra, Rashmi Kanagal-Shamana
High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance. Leukemia 36 (9) (2022)
Ayako Nogami, Koiji Sasaki
Therapeutic Advances in Immunotherapies for Hematological Malignancies. International journal of molecular sciences 23 (19) (2022)
Warren C Fiskus, Steffen Boettcher, Naval G Daver, Christopher P Mill, Koiji Sasaki, Christine E Birdwell, John A Davis, Koichi Takahashi, Tapan Mahendra Kadia, Courtney D DiNardo, Qi Jin, Yuan Qi, Xiaoping Su, Gerard M McGeehan, Joseph D Khoury, Benjamin L Ebert, Kapil N Bhalla
Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c). Blood cancer journal 12 (1) (2022)
Nicholas James Short, Gautam Borthakur, Naveen Pemmaraju, Courtney D Dinardo, Tapan M Kadia, Elias Jabbour, Marina Konopleva, Walid Macaron, Jing Ning, Junsheng Ma, Sherry Pierce, Yesid Alvarado, Koiji Sasaki, Koichi Takahashi, Zeev E Estrov, Lucia Masarova, Ghayas C Issa, Guillermo Montalban-Bravo, Michael Andreeff, Jan A Burger, Darla Miller, Lynette Alexander, Aung Naing, Guillermo Garcia-Manero, Farhad Ravandi, Naval Daver
A multi-arm phase Ib/II study designed for rapid, parallel evaluation of novel immunotherapy combinations in relapsed/refractory acute myeloid leukemia. Leukemia & lymphoma 63 (9) (2022)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Jeffrey Skinner, Sara Dellasala, Musa Ylimaz, Alessandra Ferrajoli, Prithviraj Bose, Philip Thompson, Yesid Alvarado, Nitin Jain, Guillermo Garcia Manero, Koichi Takahashi, Gautam Borthakur, Naveen Pemmaraju, Sherry Pierce, Hagop M Kantarjian
Low-dose dasatinib 50 mg/day versus standard-dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis. American journal of hematology 97 (11) (2022)
Lucia Masarova, Prithviraj Bose, Naveen Pemmaraju, Naval G Daver, Koiji Sasaki, Helen T Chifotides, Lingsha Zhou, Hagop M Kantarjian, Zeev E Estrov, Srdan Verstovsek
Improved survival of patients with myelofibrosis in the last decade: Single-center experience. Cancer 128 (8) (2022)
Tapan Mahendra Kadia, Patrick K Reville, Xuemei Wang, Caitlin R Rausch, Gautam Borthakur, Naveen Pemmaraju, Naval G Daver, Courtney D DiNardo, Koiji Sasaki, Ghayas C Issa, Maro Ohanian DO, Guillermo Montalban-Bravo, Nicholas James Short, Nitin Jain, Alessandra Ferrajoli, Kapil N Bhalla, Elias J Jabbour, Koichi Takahashi, Rashmi Malla, Kelly Quagliato, Rashmi Kanagal-Shamana, Sairah A Ahmed, Michael Andreeff, Guillermo Garcia Manero, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (33) (2022)
Elias J Jabbour, Nicholas James Short, Nitin Jain, Nadya J Jammal, Jeffrey Jorgensen, Sa Wang, Xuemei Wang, Maro Ohanian DO, Yesid Alvarado, Tapan Mahendra Kadia, Koiji Sasaki, Rebecca Garris, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian
Blinatumomab is associated with favorable outcomes in patients with B-cell lineage acute lymphoblastic leukemia and positive measurable residual disease at a threshold of 10 -4 and higher. American journal of hematology 97 (9) (2022)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D Di Nardo, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Joseph D Khoury, Sergej Konoplev, Sanam Loghavi, Keyur Patel, Guillermo Montalban Bravo, Lucia Masarova, Marina Y Konopleva, Hagop Kantarjian
Prediction of survival with intensive chemotherapy in acute myeloid leukemia. American journal of hematology 97 (7) (2022)
Shilpa Paul, Hagop Kantarjian, Koiji Sasaki, Kayleigh Marx, Nitin Jain, J Michael Savoy, Adam J DiPippo, Nadya Jammal, Guillermo Montalban Bravo, Tapan Mahendra Kadia, Guillermo Garcia Manero, Nicholas James Short, Farhad Ravandi, Elias J Jabbour
Intrathecal prophylaxis with 12 versus 8 administrations reduces the incidence of central nervous system relapse in patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia. American journal of hematology (2022)
Aram Bidikian, Hagop M Kantarjian, Elias J Jabbour, Nicholas James Short, Keyur Pravinchandra Patel, Farhad Ravandi, Koiji Sasaki, Ghayas C Issa
Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia. Blood cancer journal 12 (10) (2022)
Courtney D Di Nardo, Sangeetha Venugopal, Curtis A Lachowiez, Koichi Takahashi, Sanam Loghavi, Guillermo Montalban-Bravo, Xuemei Wang, Hetty E Carraway, Mikkael A Sekeres, Ameenah Sukkur, Danielle Hammond, Kelly Sharon Chien, Abhishek Maiti, Lucia Masarova, Koiji Sasaki, Yesid Alvarado, Tapan M Kadia, Nicholas James Short, Naval G Daver, Gautam Borthakur, Farhad Ravandi, Hagop M Kantarjian, Bhumika J Patel, Amy E DeZern, Gail J Roboz, Guillermo Garcia-Manero
Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome. Blood advances (2022)
Nicholas James Short, Walid Macaron, Marina Y Konopleva, Farhad Ravandi, Nitin Jain, Ghayas C Issa, Tapan Mahendra Kadia, Koiji Sasaki, Partow Kebriaei, Musa Ylimaz, Philip A Thompson, Koichi Takahashi, Hussein A Abbas, William G Wierda, Rebecca Garris, Hagop M Kantarjian, Elias J Jabbour
Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab. American journal of hematology 97 (6) (2022)
Curtis A Lachowiez, Patrick K Reville, Hagop M Kantarjian, Elias J Jabbour, Gautam Borthakur, Naval G Daver, Ghayas C Issa, Ken Furudate, Tomoyuki Tanaka, Sherry Pierce, Guillin Tang, Keyur P Patel, Jeffrey Medeiros, Hussein A Abbas, Fady Gh Haddad, Daniel Hammond, Nicholas James Short, Abhishek Maiti, Musa Ylimaz, Koiji Sasaki, Koichi Takahashi, Naveen Pemmaraju, Marina Y Konopleva, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia, Sanam Loghavi, Courtney D Di Nardo
Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment. American journal of hematology 97 (11) (2022)
Kumiko Chino, Hagop M Kantarjian, Nicholas James Short, Feng Wang, Ken Furudate, Hidetaka Uryu, Rebecca Garris, Nitin Jain, Koiji Sasaki, Farhad Ravandi, Marina Y Konopleva, Guillermo Garcia Manero, Latasha Little, Curtis Gumbs, Li Zhao, P Andrew Futreal, Koichi Takahashi, Elias J Jabbour
Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib. Leukemia 36 (5) (2022)
Alexandre Bazinet, Faezeh Darbaniyan, Tapan Mahendra Kadia, Sangeetha Venugopal, Rashmi Kanagal-Shamana, Courtney D Di Nardo, Gautam Borthakur, Elias J Jabbour, Naval G Daver, Naveen Pemmaraju, Marina Y Konopleva, Farhad Ravandi, Koiji Sasaki, Kelly S Chien, Danielle Hammond, Sherry A Pierce, Hagop M Kantarjian, Guillermo Garcia Manero, Guillermo Montalban Bravo
A retrospective study of cladribine and low-dose cytarabine-based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia. Cancer (2022)
E Dan Nichols, Elias J Jabbour, Nadya Jammal, Serena Chew, Jeffrey Bryan, Ghayas C Issa, Guillermo Garcia Manero, Koiji Sasaki, Adam J DiPippo, Hagop Kantarjian
Real-life incidence of thrombotic events in leukemia patients treated with ponatinib. American journal of hematology 97 (9) (2022)
Warren C Fiskus, Naval G Daver, Steffen Boettcher, Christopher P Mill, Koiji Sasaki, Christine E Birdwell, John A Davis, Kaberi Das, Koichi Takahashi, Tapan Mahendra Kadia, Courtney D Di Nardo, Francis Burrows, Sanam Loghavi, Joseph D Khoury, Benjamin L Ebert, Kapil N Bhalla
Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1. Leukemia 36 (11) (2022)
Kunhwa Kim, Marina Y Konopleva, Courtney D Di Nardo, Gautam Borthakur, Sanam Loghavi, Guillin Tang, Naval G Daver, Naveen Pemmaraju, Elias J Jabbour, Caitlin R Rausch, Musa Ylimaz, Koiji Sasaki, Nicholas James Short, Nitin Jain, Mark Brandt, Sherry Pierce, Guillermo Garcia Manero, Farhad Ravandi, Hagop Kantarjian, Tapan Mahendra Kadia
Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials. American journal of hematology 97 (7) (2022)
Musa Ylimaz, Hagop M Kantarjian, Nicholas James Short, Patrick K Reville, Marina Y Konopleva, Tapan Mahendra Kadia, Courtney D Di Nardo, Gautam Borthakur, Naveen Pemmaraju, Abhishek Maiti, Elias J Jabbour, Nitin Jain, Ghayas C Issa, Koichi Takahashi, Koiji Sasaki, Maro Ohanian, Sherry Pierce, Guillin Tang, Sanam Loghavi, Keyur Pravinchandra Patel, Sa A Wang, Guillermo Garcia Manero, Michael Andreeff, Farhad Ravandi, Naval G Daver
Hypomethylating agent and venetoclax with FLT3 inhibitor "triplet" therapy in older/unfit patients with FLT3 mutated AML. Blood cancer journal 12 (5) (2022)
Yoshihiro Umezawa, Koiji Sasaki
Dose optimization of tyrosine kinase inhibitor therapy in chronic myeloid leukemia. International journal of hematology (2022)
Jayastu Senapati, Koiji Sasaki
Chromosomal Instability in Chronic Myeloid Leukemia: Mechanistic Insights and Effects. Cancers 14 (10) (2022)
Ghayas C Issa, Aram Bidikian, Sangeetha Venugopal, Marina Y Konopleva, Courtney D Di Nardo, Tapan M Kadia, Gautam Borthakur, Elias J Jabbour, Naveen Pemmaraju, Musa Yilmaz, Nicholas James Short, Abhishek Maiti, Koiji Sasaki, Lucia Masarova, Sherry R Pierce, Koichi Takahashi, Guilin Tang, Sanam Loghavi, Keyur Pravinchandra Patel, Michael Andreeff, Kapil N Bhalla, Guillermo Garcia-Manero, Farhad Ravandi, Hagop M Kantarjian, Naval G Daver
Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML. Blood advances (2022)
Naveen Pemmaraju, Nathaniel R Wilson, Guillermo Garcia-Manero, Koiji Sasaki, Joseph D Khoury, Nitin Jain, Gautam Borthakur, Farhad Ravandi, Naval G Daver, Tapan Kadia, Courtney D Di Nardo, Elias Jabbour, Sherry Pierce, Muzaffar Qazilbash, Marina Y Konopleva, Hagop Kantarjian
Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD. Blood advances 6 (10) (2022)
Fadi Haddad, Hagop Kantarjian, Ghayas C Issa, Elias Jabbour, Koiji Sasaki
Intracranial hypertension associated with BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia. Leukemia & lymphoma 63 (7) (2022)
Patrick K Reville, Koiji Sasaki, Hagop M Kantarjian, Naval G Daver, Musa Ylimaz, Courtney D Di Nardo, Nicholas James Short, Gautam Borthakur, Naveen Pemmaraju, Rohtesh S Mehta, Sherry Pierce, Sergej N Konoplev, Joseph D Khoury, Guillermo Garcia Manero, Marina Y Konopleva, Elias Jabbour, Farhad Ravandi, Tapan Mahendra Kadia
Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification. American journal of hematology 97 (3) (2022)
Fady Gh Haddad, Koiji Sasaki, Ghayas C Issa, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia, Jorge E Cortes, Marina Y Konopleva, Naveen Pemmaraju, Yesid Alvarado, Musa Ylimaz, Gautam Borthakur, Courtney D Di Nardo, Nitin Jain, Naval G Daver, Nicholas James Short, Elias J Jabbour, Hagop Kantarjian
Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors. American journal of hematology 97 (7) (2022)
Koiji Sasaki, Hagop M Kantarjian, Kiyomi Morita, Nicholas James Short, Marina Konopleva, Nitin Jain, Farhad Ravandi, Guillermo Garcia Manero, Sa Wang, Joseph D Khoury, Jeffrey L Jorgensen, Richard E Champlin, Issa F Khouri, Partow Kebriaei, Heather M Schroeder, Maria Khouri, Rebecca Garris, Koichi Takahashi, Susan M O'Brien, Elias J Jabbour
Hyper-CVAD plus ofatumumab versus hyper-CVAD plus rituximab as frontline therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis. Cancer 127 (18) (2021)
Courtney D Di Nardo, Curtis A Lachowiez, Koichi Takahashi, Sanam Loghavi, Lianchun Xiao, Tapan Mahendra Kadia, Naval G Daver, Maria Adeoti, Nicholas James Short, Koiji Sasaki, Sa Wang, Gautam Borthakur, Ghayas Issa, Abhishek Maiti, Yesid Alvarado, Naveen Pemmaraju, Guillermo Montalban Bravo, Lucia Masarova, Musa Yilmaz, Nitin Jain, Michael Andreeff, Elias J Jabbour, Guillermo Garcia Manero, Steven M Kornblau, Farhad Ravandi, Marina Y Konopleva, Hagop M Kantarjian
Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (25) (2021)
Rashmi Kanagal-Shamana, Guillermo Montalban-Bravo, Koiji Sasaki, Faezeh Darbaniyan, Elias J Jabbour, Carlos Bueso-Ramos, Yue Wei, Kelly Chien, Tapan Mahendra Kadia, Farhad Ravandi, Gautam Borthakur, Kelly A Soltysiak, Mark Routbort, Keyur Patel, Sherry Pierce, L Jeffrey Medeiros, Hagop M Kantarjian, Guillermo Garcia Manero
Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes. Cancer 127 (19) (2021)
Kiyomi Morita, Koiji Sasaki
Current status and novel strategy of CML. International journal of hematology 113 (5) (2021)
Kunhwa Kim, Abhishek Maiti, Sanam Loghavi, Rasoul Pourebrahim, Tapan Mahendra Kadia, Caitlin R Rausch, Ken Furudate, Naval G Daver, Yesid Alvarado, Maro Ohanian, Koiji Sasaki, Nicholas James Short, Koichi Takahashi, Musa Yilmaz, Guilin Tang, Farhad Ravandi, Hagop M Kantarjian, Courtney D Di Nardo, Marina Y Konopleva
Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclax. Cancer 127 (20) (2021)
Guillermo Montalban Bravo, Rashmi Kanagal-Shamana, Faezeh Darbaniyan, Maria Tariq Siddiqui, Koiji Sasaki, Yue Wei, Hui Yang, Kelly Sharon Chien, Kiran Naqvi, Elias J Jabbour, Tapan Mahendra Kadia, Naval G Daver, Courtney D Di Nardo, Farhad Ravandi, Naveen Pemmaraju, Prithviraj Bose, Srdan Verstovsek, Sherry Pierce, Carlos Bueso-Ramos, Keyur Patel, Kim-Anh Do, Hagop M Kantarjian, Guillermo Garcia Manero
Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS). American journal of hematology 96 (7) (2021)

Koiji Sasaki.css-eqlu8i{font-size:small;padding-left:4px;} (Koji Sasaki)

Publication Activity (10 Years)

Top Topics

Top Venues

Koiji Sasaki (Koji Sasaki)